Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/29122
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seyhan, Ayşe | - |
dc.contributor.author | Polat, Mehtap | - |
dc.contributor.author | Son, Weon-Young | - |
dc.contributor.author | Yaralı, Hakan | - |
dc.contributor.author | Dahan, Michael H. | - |
dc.date.accessioned | 2022-10-17T12:28:20Z | - |
dc.date.available | 2022-10-17T12:28:20Z | - |
dc.date.issued | 2013-08 | - |
dc.identifier.citation | Seyhan, A. vd. (2013). "Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG". Human Reproduction, 28(9), 2522-2528. | en_US |
dc.identifier.issn | 0268-1161 | - |
dc.identifier.issn | 1460-2350 | - |
dc.identifier.uri | https://doi.org/10.1093/humrep/det124 | - |
dc.identifier.uri | https://academic.oup.com/humrep/article/28/9/2522/597077 | - |
dc.identifier.uri | http://hdl.handle.net/11452/29122 | - |
dc.description.abstract | Is severe early ovarian hyperstimulation syndrome (OHSS) completely prevented with the GnRH agonist trigger and 1500 IU hCG luteal rescue protocol? Severe early OHSS can occur even after the GnRH agonist trigger and 1500 IU hCG luteal rescue protocol. Prior studies including over 200 women who received the GnRH agonist trigger and 1500 hCG luteal rescue protocol have reported complete prevention of severe early OHSS. Only a few late OHSS cases have been reported and it has been suggested that this protocol can be safely applied to any women under risk. This retrospective cohort study included all women who were at high risk of OHSS and were given the GnRH agonist trigger plus hCG luteal rescue protocol between December 2008 and August 2012 in the two participating centers. There were 23 women with a mean estradiol level of 4891 2214 pg/ml and a mean number of 12 mm follicles of 20 6 on the day of ovulation triggering. OHSS was categorized according to the Golan criteria. Overall 6 of the 23 (26) women developed severe OHSS. Five women had severe early OHSS requiring ascites drainage and hospitalization and three of these women did not undergo embryo transfer. The number of follicles measuring 1014 mm on the day of triggering was significantly different between women who developed severe early OHSS and those who did not. The small number of women with severe early OHSS may have prevented identification of other significant risk factors. Although the GnRH agonist plus 1500 IU hCG luteal rescue protocol significantly decreases the risk of severe OHSS, this life threatening complication can still occur in high-risk patients. It would be prudent to avoid hCG luteal rescue and freeze all embryos for future transfer in such women particularly when there are 18 follicles with 1014 mm diameters even with few larger follicles. No funding was sought for this report. The authors have no conflict of interest to declare. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford University | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Obstetrics & gynecology | en_US |
dc.subject | Reproductive biology | en_US |
dc.subject | Ovarian hyperstimulation syndrome | en_US |
dc.subject | hCG | en_US |
dc.subject | GnRH agonist | en_US |
dc.subject | GnRH antagonist | en_US |
dc.subject | In vitro fertilization | en_US |
dc.subject | Low-dose HCG | en_US |
dc.subject | Final oocyte maturation | en_US |
dc.subject | Rescue | en_US |
dc.subject | Combination | en_US |
dc.subject | Prevention | en_US |
dc.subject | Cycles | en_US |
dc.subject | Ohss | en_US |
dc.subject | GnRH agonist | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Buserelin | en_US |
dc.subject.mesh | Chorionic gonadotropin | en_US |
dc.subject.mesh | Cohort studies | en_US |
dc.subject.mesh | Corpus luteum | en_US |
dc.subject.mesh | Estradiol | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Fertility agents, female | en_US |
dc.subject.mesh | Fertilization in vitro | en_US |
dc.subject.mesh | Gonadotropin-releasing hormone | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infertility, female | en_US |
dc.subject.mesh | Ovarian hyperstimulation syndrome | en_US |
dc.subject.mesh | Ovary | en_US |
dc.subject.mesh | Ovulation induction | en_US |
dc.subject.mesh | Quebec | en_US |
dc.subject.mesh | Retrospective studies | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.subject.mesh | Severity of illness index | en_US |
dc.subject.mesh | Triptorelin pamoate | en_US |
dc.subject.mesh | Turkey | en_US |
dc.title | Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000323596400024 | tr_TR |
dc.identifier.scopus | 2-s2.0-84883175768 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Dölerme ve Suni Tohumlama Anabilim Dalı/Yardımlı Üreme Birimi. | tr_TR |
dc.contributor.orcid | 0000-0003-1106-3747 | tr_TR |
dc.identifier.startpage | 2522 | tr_TR |
dc.identifier.endpage | 2528 | tr_TR |
dc.identifier.volume | 28 | tr_TR |
dc.identifier.issue | 9 | tr_TR |
dc.relation.journal | Human Reproduction | en_US |
dc.contributor.buuauthor | Ata, Barış | - |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 23633553 | tr_TR |
dc.subject.wos | Obstetrics & gynecology | en_US |
dc.subject.wos | Reproductive biology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q1 | en_US |
dc.contributor.scopusid | 16306205100 | tr_TR |
dc.subject.scopus | Chorionic Gonadotropin; Gnrh Agonist; Cabergoline | en_US |
dc.subject.emtree | Buserelin | en_US |
dc.subject.emtree | Buserelin acetate | en_US |
dc.subject.emtree | Chorionic gonadotropin | en_US |
dc.subject.emtree | Dopamine receptor stimulating agent | en_US |
dc.subject.emtree | Estradiol | en_US |
dc.subject.emtree | Estradiol valerate | en_US |
dc.subject.emtree | Infusion fluid | en_US |
dc.subject.emtree | Low molecular weight heparin | en_US |
dc.subject.emtree | Metformin | en_US |
dc.subject.emtree | Progesterone | en_US |
dc.subject.emtree | Triptorelin | en_US |
dc.subject.emtree | Abdominal distension | en_US |
dc.subject.emtree | Abdominal pain | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Ascites | en_US |
dc.subject.emtree | Blastocyst | en_US |
dc.subject.emtree | Bloating | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Cohort analysis | en_US |
dc.subject.emtree | Disease severity | en_US |
dc.subject.emtree | Dyspnea | en_US |
dc.subject.emtree | Embryo transfer | en_US |
dc.subject.emtree | Estradiol blood level | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Fertilization in vitro | en_US |
dc.subject.emtree | High risk patient | en_US |
dc.subject.emtree | Hospitalization | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hyperandrogenism | en_US |
dc.subject.emtree | Luteal phase | en_US |
dc.subject.emtree | Oocyte retrieval | en_US |
dc.subject.emtree | Ovary follicle cell | en_US |
dc.subject.emtree | Ovary hyperstimulation | en_US |
dc.subject.emtree | Ovulation | en_US |
dc.subject.emtree | Pregnancy | en_US |
dc.subject.emtree | Spontaneous abortion | en_US |
dc.subject.emtree | Vomiting | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.